Mr. Lev Gerlovin has 20 years of consulting experience across strategic planning, litigation, and policy spheres. His recent focus has been in leading strategy engagements for a diverse set of clients, including major pharmaceutical and biotechnology manufacturers, distributors, health plan providers, and industry groups.
Mr. Gerlovin has managed projects spanning commercial strategy, product design and optimization, pricing and market access, product launch, portfolio lifecycle management, channels and distribution, sales and marketing effectiveness, and organizational design. He has broad therapeutic category experience, particularly in diabetes, endocrinology, neurology, hematology, oncology, rheumatology, CNS, infectious diseases, and rare diseases.
MBA and MS Finance, Boston College
BA magna cum laude, Economics, Harvard College